Health practices and vaginal microbicide acceptability among urban black women.
Health practices and vaginal microbicide acceptability among urban black women.
复制标题
城市黑人女性的健康习惯和阴道杀菌剂的可接受性。
DOI：
10.1089/jwh.2008.0886
复制
发表时间：
2008
期刊：
影响因子：
--
通讯作者：
Cushman,LindaF
中科院分区：
文献类型：
--
作者：
Reiff,Marian;Wade,Christine;Chao,MariaT;Kronenberg,Fredi;Cushman,LindaF
背景：阴道内外用杀微生物剂用于预防HIV传播正在研究中。使用阴道杀微生物剂将构成一种新型的做法，发生在与避孕、卫生和自我保健有关的其他阴道做法的背景下，这些做法受到文化规范和个人信仰的影响。鉴于黑人女性艾滋病毒感染率很高，需要对该人群中与杀微生物剂可接受性相关的实践和决策进行研究。方法：纽约市的23名年龄在25-64岁之间的黑人女性完成了面对面的半结构化访谈和自我管理问卷。定量分析检查阴道的做法和意愿，使用杀微生物剂。定性分析探讨了潜在的决策过程中涉及的选择阴道的做法和一般healthcare.Results：愿意使用阴道产品预防艾滋病病毒是很高的，特别是在更多的受过教育的妇女。安全性是一个主要问题，女性对使用阴道产品持谨慎态度。一些人认为合成产品具有潜在的有害副作用，而另一些人则认为天然产品由于测试不足而具有风险。阴道的做法的选择受到影响的风险和疗效，以前的经验，文化背景，和一般的方法healthcare.Conclusions的评估：大多数妇女的样本中表示愿意使用阴道产品预防艾滋病毒。关于阴道实践的决策过程是复杂的，并受到社会，文化和个人因素的影响。虽然具体的偏好可能会有所不同，但当副作用最小且产品被认为安全时，对使用阴道产品的态度可能是积极的。
Background:Intravaginal topical microbicides are being investigated for prevention of HIV transmission. Use of vaginal microbicides will constitute a new type of practice, occurring in the context of other vaginal practices related to contraception, hygiene, and self-care, which are affected by cultural norms and personal beliefs. Given the high rate of HIV infection among black women, research on practices and decision making relevant to microbicide acceptability is needed in this population.Methods:Twenty-three black women in New York City, aged 25–64, completed in-person semistructured interviews and self-administered questionnaires. Quantitative analyses examined vaginal practices and willingness to use microbicides. Qualitative analyses explored underlying decision-making processes involved in choices regarding vaginal practices and general healthcare.Results:Willingness to use vaginal products for HIV prevention was high, especially among more educated women. Safety was a major concern, and women were cautious about using vaginal products. Whereas some viewed synthetic products as having potentially harmful side effects, others perceived natural products as risky because of insufficient testing. Choices about vaginal practices were affected by assessments of risk and efficacy, prior experience, cultural background, and general approach to healthcare.Conclusions:The majority of women in the sample expressed willingness to use a vaginal product for HIV prevention. Decision-making processes regarding vaginal practices were complex and were affected by social, cultural, and personal factors. Although specific preferences may vary, attitudes toward using a vaginal product are likely to be positive when side effects are minimal and the product is considered safe.